Oxygen Therapy for Brain Damage: Evidence, Protocols, and What to Expect

Oxygen therapy, specifically hyperbaric oxygen therapy (HBOT), is one of the few treatments showing measurable results for acquired brain injuries that conventional medicine considers permanent. From traumatic brain injury (TBI) to near-drowning events to carbon monoxide poisoning, the common thread is oxygen-deprived brain tissue that may still be salvageable. Research from the past two decades suggests that delivering oxygen under pressure can reactivate damaged but surviving neurons, even years after the initial injury.

This guide covers the evidence for HBOT across different types of brain damage, the biological mechanisms involved, treatment protocols, costs, and practical considerations for patients exploring this option.

Types of Brain Damage Treated with HBOT

Acquired brain injury is an umbrella term covering any brain damage that occurs after birth. The causes vary, but the underlying pathology often shares common features: oxygen deprivation, inflammation, and impaired blood flow to affected brain regions.

How HBOT Works for Brain Damage

The brain consumes roughly 20% of the body’s oxygen despite representing only 2% of body weight. When oxygen delivery is compromised, brain cells are uniquely vulnerable.

HBOT addresses brain damage through several interconnected mechanisms:

• Hyperoxygenation: Breathing 100% oxygen at 1.5 to 2.0 ATA increases dissolved oxygen in blood plasma by 10 to 15 times, bypassing damaged hemoglobin and reaching areas with compromised blood flow
• Neuroplasticity activation: Elevated oxygen levels upregulate hypoxia-inducible factor 1-alpha (HIF-1α) and brain-derived neurotrophic factor (BDNF), promoting the formation of new neural connections²
• Anti-inflammatory effects: HBOT reduces levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) that contribute to secondary brain injury
• Angiogenesis: New blood vessel formation improves perfusion to oxygen-starved brain regions over the course of treatment
• Stem cell mobilization: HBOT increases circulating stem cells from bone marrow by up to 800% after 20 sessions, which may contribute to neural repair⁴

The concept of the ischemic penumbra applies to brain damage beyond stroke. In many cases, a zone of metabolically compromised but structurally intact tissue surrounds the core injury. These cells are alive but functionally dormant. HBOT provides the metabolic substrate (oxygen) needed to reactivate them.

Evidence by Cause

Carbon Monoxide Poisoning

This is the best-established use of HBOT for brain damage. Carbon monoxide binds to hemoglobin with 200 to 250 times the affinity of oxygen, displacing oxygen and causing cellular hypoxia throughout the body, with the brain being most severely affected.

Weaver et al. (2002) conducted a double-blind RCT of 152 patients with acute CO poisoning. The HBOT group received three sessions at 3.0 ATA within 24 hours. At six weeks, cognitive sequelae occurred in 25% of the HBOT group versus 46.1% of the normobaric oxygen group. At 12 months, the benefit persisted: 15.7% versus 31.8%.³

HBOT accelerates CO dissociation from hemoglobin (half-life drops from 320 minutes on room air to 23 minutes at 3.0 ATA) and addresses the secondary mechanisms of CO toxicity, including lipid peroxidation and inflammatory cascades.

Traumatic Brain Injury

TBI research has produced the most studies but also the most debate. The challenge is that TBI varies enormously in severity, location, and mechanism, making it difficult to design one-size-fits-all trials.

Hadanny et al. (2022) conducted a randomized controlled trial of 63 post-TBI patients (1 to 5 years after injury) comparing HBOT (60 sessions at 2.0 ATA) with a sham control. The HBOT group showed significant improvements in cognitive function, psychiatric symptoms (depression, anxiety), pain, and sleep quality. MRI showed improvements in brain microstructure and cerebral blood flow.²

“HBOT induced neuroplasticity and improved cognitive, psychiatric, fatigue, sleep, and pain symptoms of patients suffering from mild TBI at late chronic stage, years after injury.”
Hadanny et al., 2022, Scientific Reports

Military TBI research has been particularly active. The Department of Defense funded several large trials, including the HOPPS and BIMA studies, which produced mixed results. However, critics note that the “sham” condition in these studies (1.3 ATA air) may itself be an active treatment, potentially explaining why both groups improved.

Near-Drowning and Anoxic Injury

Evidence for near-drowning is limited to case reports and small case series, but some results are striking. Harch et al. (2017) published the case of a two-year-old who suffered a drowning event with 15 minutes of submersion. Following 40 sessions of HBOT at 1.3 ATA and then 1.5 ATA, the child showed reversal of brain atrophy on MRI and near-normalization of neurological function.¹

While case reports cannot establish causation, this case was notable because recovery occurred months after the injury, when spontaneous improvement was considered extremely unlikely.

The Harch Protocol

Dr. Paul Harch, a pioneer in HBOT for brain injury, developed a lower-pressure protocol that differs from the higher-pressure protocols used in acute care:

Harch argues that injured brain tissue is more sensitive to oxygen and that lower pressures are better tolerated for the extended treatment courses brain injuries require. This protocol has not been validated in large RCTs but has been used in numerous published case reports and series.

Timing: Does It Matter?

One of the most important findings in the HBOT-brain injury literature is that treatment may be effective long after the initial injury. The Hadanny TBI trial enrolled patients 1 to 5 years post-injury. Case reports have documented improvement years and even decades after the original event.

This matters because most brain injury rehabilitation focuses on the acute and subacute phases (the first 6 to 12 months). Patients who do not recover sufficiently during this window are often told they have reached their maximum improvement. HBOT research suggests this may not be the final answer.

That said, earlier treatment is generally preferred when feasible. The longer brain tissue remains dormant, the higher the risk of irreversible atrophy. For CO poisoning specifically, treatment within 24 hours of exposure yields the best outcomes.³

Cost and Insurance

HBOT sessions for brain injury typically cost $150 to $350 per session at independent clinics. Hospital-based hyperbaric facilities may charge $500 to $1,500 per session.

A typical 40-session protocol costs $6,000 to $14,000 at independent clinics. Extended protocols of 60 to 80 sessions can reach $28,000.

Insurance covers HBOT for carbon monoxide poisoning (FDA-cleared indication). Coverage for TBI, near-drowning, and other brain injuries is almost always denied as “experimental.” Some veterans have accessed HBOT for TBI through VA hospitals or nonprofit organizations that fund treatment for veterans.

Safety Considerations

HBOT is considered safe when administered in clinical-grade chambers by trained operators. Side effects are generally mild:

• Ear and sinus barotrauma (most common, manageable with equalization)
• Temporary changes in vision (reversible myopia)
• Fatigue following sessions
• Rare: oxygen toxicity seizures (fewer than 1 in 10,000 sessions)

Patients with brain injuries should be evaluated for seizure risk before starting HBOT, as the injured brain may have a lower seizure threshold. Proper screening and gradual pressure increases can mitigate this risk.

The Bottom Line

HBOT for brain damage is supported by strong evidence for carbon monoxide poisoning, moderate evidence for TBI, and emerging evidence for other forms of acquired brain injury. The biological rationale is sound: damaged but viable brain tissue needs oxygen to recover, and HBOT delivers oxygen at concentrations that normal breathing cannot match.

The biggest barrier is not safety or science but access and cost. Most insurance plans do not cover HBOT for off-label brain injury indications, placing the financial burden on patients. For those who can access it, the therapy offers a chance at neurological improvement when other options have been exhausted.

Related reading: Hyperbaric Chamber for Brain Injury: Complete Guide

References

1. Harch PG, Andrews SR, Fogarty EF, et al. Case report: hyperbaric treatment of global cerebral ischemia/anoxia from drowning in a 2-year-old child. Med Gas Res. 2017;7(3):195-199. doi:10.4103/2045-9912.215749
2. Hadanny A, Catalogna M, Yaniv S, et al. Hyperbaric oxygen therapy improves neurocognitive functions in post-concussion syndrome – randomized controlled trial. Sci Rep. 2022;12(1):508. doi:10.1038/s41598-022-04565-5
3. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;347(14):1057-1067. doi:10.1056/NEJMoa013121
4. Thom SR, Bhopale VM, Velazquez OC, et al. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006;290(4):H1378-H1386. doi:10.1152/ajpheart.00888.2005

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website